Bristol-Myers Squibb Co (BMY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

430 E. 29TH STREET NEW YORK, NY 10016

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. The Company has three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments Nutritionals and ConvaTec comprise the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of the ostomy, wound and skin care business.

Data as of 2020-05-24
Market Cap137.549 Billion Shares Outstanding2.263 Billion Avg 30-day Volume15.556 Million
P/E Ratio98.0 Dividend Yield2.961 EPS0.62
Price/Sales4.436 Price cash flow ratio10.7 Price free cash flow ratio-67.7
Book Value22.06 Price to Tangible Book-4.02 Alpha-0.0
Short Interest Ratio2.05 % Short Interest to Float1.4 R-squared0.170144
BETA0.74039 52-week High/Low68.34 / 42.48 Stddev0.076227
View SEC Filings from BMY instead.

View recent insider trading info

 
Bristol-Myers Squibb Co Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BMY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

28.2 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

13.6 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DUBOW ADAM SVP,CHIEFCOMPLIANCE&ETHICSOFF.

  • Officer
 17,023 2020-05-22 3

SATO VICKI L

  • Director
 0 2020-05-21 1

CUSS FRANCIS M

  • Director
 0 2020-05-21 0

HOOPER ANTHONY C

  • Director
 0 2020-05-21 0

BERTOLINI ROBERT J

  • Director
 29,134 2020-05-20 6

SCHMUKLER LOUIS S EVP,PRES.,GLOB.PROD. & SUPPLY

  • Officer
 26,777 2020-05-19 3

SAMUELS THEODORE R. II

  • Director
 27,908 2020-05-15 5

YALE PHYLLIS R

  • Director
 7,723 2020-05-15 5

PALIWAL DINESH C

  • Director
 0 2020-05-12 5

JOHANSSON LEIF

  • Director
 16,293 2020-05-07 0

WILLIAMS R SANDERS

  • Director
 5,409 2020-05-05 0

GORDON MURDO EVP GLOBAL COMMERCIAL OPS

  • Officer
 37,873 2020-05-05 0

AHMED NADIM EVP AND PRESIDENT, HEMATOLOGY

  • Officer
 27,996 2020-05-01 9

VESSEY RUPERT EVP, RESEARCH & EARLY DEV.

  • Officer
 54,389 2020-05-01 11

ANDREOTTI LAMBERTO

  • Director
 20,923 2020-04-28 0

BANCROFT CHARLES A

  • Director
 0 2020-04-02 2

MILY ELIZABETH EVP, STRATEGY & BD

  • Officer
 0 2020-04-01 3

GROBSTEIN MICHAEL

  • Director
 0 2020-03-31 5

STORCH GERALD L

  • Director
 0 2020-03-31 5

LACY ALAN J

  • Director
 0 2020-03-31 5

ARDUINI PETER J

  • Director
 0 2020-03-31 5

EMMENS MATTHEW

  • Director
 0 2020-03-31 5

VOUSDEN KAREN H

  • Director
 0 2020-03-31 5

HALLER JULIA A

  • Director
 0 2020-03-31 6

BONNEY MICHAEL W

  • Director
 0 2020-03-31 6

BIONDI PAUL

  • Director
 0 2020-03-20 1

LEUNG SANDRA EVP, GENERAL COUNSEL

  • Officer
 580,563 2020-03-10 1

CAFORIO GIOVANNI CHAIRMAN AND CEO

  • Officer
  • Director
 485,424 2020-03-10 2

VON AUTENRIED PAUL EVP, CHIEF INFORMATION OFFICER

  • Officer
 146,701 2020-03-10 1

ELICKER JOHN E EVP, INVESTOR RELATIONS

  • Officer
 70,946 2020-03-10 3

POWELL ANN EVP, CHIEF HUMAN RESOURCES

  • Officer
 51,452 2020-03-10 2

SANTIAGO KAREN MURPHY CONTROLLER

  • Officer
 7,046 2020-03-10 3

BOERNER CHRISTOPHER S. EVP, CHIEF COMMERCIAL OFFICER

  • Officer
 21,033 2020-03-10 2

EID JOSEPH SVP,HEAD GLOB. MEDICAL AFFAIRS

  • Officer
 6,445 2020-03-10 4

HIRAWAT SAMIT EVP,CHIEF MED.OFFR.,DRUG DEV.

  • Officer
 0 2020-03-10 3

ELKINS DAVID V EVP, CHIEF FINANCIAL OFFICER

  • Officer
 0 2020-03-10 7

METCALFE KATHRYN EVP, CORPORATE AFFAIRS

  • Officer
 0 2020-03-10 3

DANIELS BRIAN

  • Director
 0 2020-02-11 0

CELENTANO JOHN E

  • Director
 0 2020-01-02 0

GLIMCHER LAURIE H M.D.

  • Director
 4,067 2020-01-02 0

LEVIN JEREMY M CEO

  • Officer
  • Director
  • 10% Owner
 0 2019-12-18 0

SIGAL ELLIOT

  • Director
 0 2019-12-17 0

LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
 22,223 2019-04-03 0

BASELGA JOSE

  • Director
 No longer subject to file 2018-09-30 0

STORCH GERALD L

STORCH GERALD L

  • Director
 0 2018-09-30 5

ROBINSON JAMES D III

  • Director
  • 10% Owner
 8,710,679 2018-05-29 0

HELLER FRANCES K

  • Director
 47,961 2017-10-13 0

CALDARELLA JOSEPH C SVP & CONTROLLER

  • Officer
 48,076 2017-09-06 0

NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

  • Officer
 37,974 2017-09-03 0

CORNELIUS JAMES M

  • Director
 No longer subject to file 2017-06-15 0

WEST TOGO D JR

  • Director
 0 2017-04-06 0

BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

  • Officer
 20,138 2017-03-10 0

CAMPBELL LEWIS B

  • Director
 2,110 2016-03-08 0

MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

  • Officer
 31,615 2015-03-13 0

CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

  • Officer
 177,118 2013-05-31 0

FREEH LOUIS J

  • Director
 0 2013-02-01 0

CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

  • Officer
 8,432 2011-06-14 0

ZITO ROBERT T SVP & CHIEF COMM OFFICER

  • Officer
 35,469 2010-03-06 0

MCBRIDE ANTHONY A SVP HUMAN RESOURCES

  • Officer
 34,292 2010-03-06 0

HUET JEAN-MARC EVP & CFO

  • Officer
 25,000 2009-04-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

DUBOW ADAM - Officer SVP,CHIEFCOMPLIANCE&ETHICSOFF.

2020-05-22 S 3,200 $61.01 d 16,086 17,023.44 direct

SCHMUKLER LOUIS S - Officer EVP,PRES.,GLOB.PROD. & SUPPLY

2020-05-19 S 25,000 $62.68 d 26,777 26,777.47 direct

VESSEY RUPERT - Officer EVP, RESEARCH & EARLY DEV.

2020-05-01 M 10,707 a 0 54,389.00 direct

AHMED NADIM - Officer EVP AND PRESIDENT, HEMATOLOGY

2020-05-01 M 2,908 a 0 27,996.00 direct

VESSEY RUPERT - Officer EVP, RESEARCH & EARLY DEV.

2020-05-01 F 5,274 $60.26 d 53,776 54,389.00 direct

AHMED NADIM - Officer EVP AND PRESIDENT, HEMATOLOGY

2020-05-01 F 1,433 $60.26 d 26,030 27,996.00 direct

VESSEY RUPERT - Officer EVP, RESEARCH & EARLY DEV.

2020-05-01 M 10,707 a 59,050 54,389.00 direct

AHMED NADIM - Officer EVP AND PRESIDENT, HEMATOLOGY

2020-05-01 M 2,908 a 27,463 27,996.00 direct

MILY ELIZABETH - Officer EVP, STRATEGY & BD

2020-04-01 A 21,973 a 21,973 0.00 direct

MILY ELIZABETH - Officer EVP, STRATEGY & BD

2020-04-01 A 14,649 a 14,649 0.00 direct

MILY ELIZABETH - Officer EVP, STRATEGY & BD

2020-04-01 A 10,738 a 10,738 0.00 direct

HALLER JULIA A - Director

2020-03-31 A 516 $55.74 a 4,369 0.00 direct

VOUSDEN KAREN H - Director

2020-03-31 A 174 $55.74 a 13,809 0.00 direct

BERTOLINI ROBERT J - Director

2020-03-31 A 628 $55.74 a 20,636 0.00 direct

SAMUELS THEODORE R. II - Director

2020-03-31 A 583 $55.74 a 19,352 0.00 direct

EMMENS MATTHEW - Director

2020-03-31 A 650 $55.74 a 20,895 0.00 direct

PALIWAL DINESH C - Director

2020-03-31 A 695 $55.74 a 33,832 0.00 direct

STORCH GERALD L - Director

2020-03-31 A 583 $55.74 a 56,604 0.00 direct

YALE PHYLLIS R - Director

2020-03-31 A 516 $55.74 a 4,369 0.00 direct

GROBSTEIN MICHAEL - Director

2020-03-31 A 314 $55.74 a 87,133 0.00 direct

ARDUINI PETER J - Director

2020-03-31 A 650 $55.74 a 25,855 0.00 direct

LACY ALAN J - Director

2020-03-31 A 583 $55.74 a 78,156 0.00 direct

BONNEY MICHAEL W - Director

2020-03-31 A 414 $55.74 a 4,215 0.00 direct

Elevate your investments